Examples of 'liraglutide' in a sentence
Meaning of "liraglutide"
Liraglutide (noun) - A medication used to treat type 2 diabetes by lowering blood sugar levels. Liraglutide is a type of glucagon-like peptide-1 (GLP-1) receptor agonist that helps regulate insulin production and decrease liver sugar production
Show more definitions
- A antidiabetic drug C₁₇₂H₂₆₅N₄₃O₅₁ (trademark Victoza) that is an analog of glucagon-like peptide 1 administered by injection in the treatment of type 2 diabetes and obesity.
How to use "liraglutide" in a sentence
Basic
Advanced
liraglutide
Liraglutide exposure increased proportionally with dose.
Victoza contains the active substance liraglutide.
Liraglutide stimulates insulin secretion in a glucosedependent manner.
Saxenda contains the active substance liraglutide.
Liraglutide is finally obtained by purification and lyophilizing.
The clinical therapeutic effect of liraglutide is encouraging.
Formulation is liraglutide in phosphate buffer without surfactant.
The active substances are insulin degludec and liraglutide.
A drop of liraglutide should appear at the needle tip.
Xultophy is a medicine that contains insulin degludec and liraglutide.
Liraglutide is not a substitute for insulin.
It is not known whether liraglutide is excreted in human milk.
Liraglutide does not increase energy expenditure compared to placebo.
The active substance is liraglutide.
Liraglutide stimulates insulin secretion in a glucose dependent manner.
See also
No severe hypoglycaemic episodes occurred in the liraglutide treatment group.
Do not freeze liraglutide or use liraglutide if it has been frozen.
There are no adequate data from the use of liraglutide in pregnant women.
Liraglutide should therefore be used with caution in these patients.
Do not use the pen if a drop of liraglutide still does not appear.
Liraglutide is usually administered parenterally.
Antibody formation has not been associated with reduced efficacy of liraglutide.
The exposure of liraglutide decreases with increasing body weight.
It is generically known as liraglutide.
Liraglutide did not reduce the plaque size of already established plaques.
It is not known whether insulin degludec or liraglutide is excreted in human milk.
Turbidimetric measurements of two pharmaceutical compositions containing aspart and liraglutide.
The cardiovascular safety of liraglutide is being investigated in an ongoing cardiovascular outcomes trial.
Victoza is a solution for injection that contains the active substance liraglutide.
Few patients treated with liraglutide reported at least one episode of severe diarrhoea.
No episodes of major hypoglycaemia were observed in the trial with liraglutide used as monotherapy.
The results demonstrated that liraglutide significantly decreased the number of viable cells without inducing apoptosis.
The contraceptive effect is therefore anticipated to be unaffected when co administered with liraglutide.
Data from clinical trials showed that liraglutide is associated with delayed gastric emptying.
Saxenda is a weight loss medicine that contains the active substance liraglutide.
Additionally the weight benefit from liraglutide was sustained when adding Levemir.
The contraceptive effect is therefore anticipated to be unaffected when coadministered with liraglutide.
Liraglutide is produced by Novo Nordisk vía genetic recombination technology.
No episodes of severe hypoglycaemia were observed in the trial with liraglutide used as monotherapy.
Absolute bioavailability of liraglutide following subcutaneous administration is approximately 55.
The safety and efficacy of dulaglutide was also investigated in an active controlled study liraglutide.
Comparison of Lixisenatide uptake with Liraglutide uptake in the brain.
Patients treated with Xultophy overall experienced less gastrointestinal side effects than patients treated with liraglutide.
In addition, liraglutide had a beneficial effect on plasma lipids.
You should not use these clicks to select the amount of liraglutide to inject.
Liraglutide was dissolved in water at room temperature and pH was adjusted to pH 10.
The following data are based upon studies with insulin degludec and liraglutide individually.
Liraglutide has been developed so that it is suitable for once-daily injection.
This will enable an increased zinc concentration with relative lower liraglutide diheptamer formation.
The heat treatments of liraglutide were carried out in solution having a pH of about 10.
